Literature DB >> 12811208

Treatment of ulcerative colitis using fecal bacteriotherapy.

Thomas J Borody1, Eloise F Warren, Sharyn Leis, Rosa Surace, Ori Ashman.   

Abstract

BACKGROUND: Although the etiology of idiopathic ulcerative colitis (UC) remains poorly understood, the intestinal flora is suspected to play an important role. Specific, consistent abnormalities in flora composition peculiar to UC have not yet been described, however Clostridium difficile colitis has been cured by the infusion of human fecal flora into the colon. This approach may also be applicable to the treatment of UC on the basis of restoration of flora imbalances. GOAL: To observe the clinical, colonoscopic and histologic effects of human probiotic infusions (HPI) in 6 selected patients with UC. CASE REPORTS: Six patients (3 men and 3 women aged 25-53 years) with UC for less than 5 years were treated with HPI. All patients had suffered severe, recurrent symptoms and UC had been confirmed on colonoscopy and histology. Fecal flora donors were healthy adults who were extensively screened for parasites and bacterial pathogens. Patients were prepared with antibiotics and oral polyethylene glycol lavage. Fecal suspensions were administered as retention enemas within 10 minutes of preparation and the process repeated daily for 5 days. By 1 week post-HPI some symptoms of UC had improved. Complete reversal of symptoms was achieved in all patients by 4 months post-HPI, by which time all other UC medications had been ceased. At 1 to 13 years post-HPI and without any UC medication, there was no clinical, colonoscopic, or histologic evidence of UC in any patient.
CONCLUSIONS: Colonic infusion of donor human intestinal flora can reverse UC in selected patients. These anecdotal results support the concept of abnormal bowel flora or even a specific, albeit unidentified, bacterial pathogen causing UC.

Entities:  

Mesh:

Year:  2003        PMID: 12811208     DOI: 10.1097/00004836-200307000-00012

Source DB:  PubMed          Journal:  J Clin Gastroenterol        ISSN: 0192-0790            Impact factor:   3.062


  124 in total

Review 1.  Review of medical and surgical management of Clostridium difficile infection.

Authors:  B Faris; A Blackmore; N Haboubi
Journal:  Tech Coloproctol       Date:  2010-05-08       Impact factor: 3.781

2.  Efficacious outcome employing fecal bacteriotherapy in severe Crohn's colitis complicated by refractory Clostridium difficile infection.

Authors:  C A Duplessis; D You; M Johnson; A Speziale
Journal:  Infection       Date:  2011-12-08       Impact factor: 3.553

3.  Reduced diversity and imbalance of fecal microbiota in patients with ulcerative colitis.

Authors:  Hideyuki Nemoto; Keiko Kataoka; Hideki Ishikawa; Kazue Ikata; Hideki Arimochi; Teruaki Iwasaki; Yoshinari Ohnishi; Tomomi Kuwahara; Koji Yasutomo
Journal:  Dig Dis Sci       Date:  2012-05-24       Impact factor: 3.199

Review 4.  Human microbiome: From the bathroom to the bedside.

Authors:  Stephen Malnick; Ehud Melzer
Journal:  World J Gastrointest Pathophysiol       Date:  2015-08-15

Review 5.  The role of the gut microbiome in systemic inflammatory disease.

Authors:  Jose C Clemente; Julia Manasson; Jose U Scher
Journal:  BMJ       Date:  2018-01-08

Review 6.  Probiotics and prebiotics in chronic inflammatory bowel diseases.

Authors:  Julia B Ewaschuk; Levinus A Dieleman
Journal:  World J Gastroenterol       Date:  2006-10-07       Impact factor: 5.742

Review 7.  The role of antibiotic and probiotic therapies in current and future management of inflammatory bowel disease.

Authors:  Julia B Ewaschuk; Qassim Z Tejpar; Isaac Soo; Karen Madsen; Richard N Fedorak
Journal:  Curr Gastroenterol Rep       Date:  2006-12

8.  Soluble proteins produced by probiotic bacteria regulate intestinal epithelial cell survival and growth.

Authors:  Fang Yan; Hanwei Cao; Timothy L Cover; Robert Whitehead; M Kay Washington; D Brent Polk
Journal:  Gastroenterology       Date:  2006-11-17       Impact factor: 22.682

Review 9.  Probiotics in the management of colonic disorders.

Authors:  Eamonn M M Quigley
Journal:  Curr Gastroenterol Rep       Date:  2007-10

10.  Protective effect of lactulose on dextran sulfate sodium-induced colonic inflammation in rats.

Authors:  György Rumi; Ryouichi Tsubouchi; Mitsuaki Okayama; Shinichi Kato; Gyula Mózsik; Koji Takeuchi
Journal:  Dig Dis Sci       Date:  2004-09       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.